Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CHC”

Showing 13 of 0 results

Not applicableStudy completedNCT04173520
What this trial is testing

ELRIAH Score: A Simple Score for HCC Risk Stratification in CHC Patients With Cirrhosis or Advanced Liver Fibrosis Who Achieved SVR Following DAA Therapy

Who this might be right for
HCC
Egyptian Liver Hospital 2,326
Not applicableStudy completedNCT03063723
What this trial is testing

Dynamic Changes of Monocytes and NK Cells of CHC Patient Treated by DAAs

Who this might be right for
Chronic Hepatitis C (Disorder)
Third Affiliated Hospital, Sun Yat-Sen University 25
Large-scale testing (Phase 3)Study completedNCT03020082
What this trial is testing

Efficacy and Safety of Danoprevir/r + PR 12week Triple Therapy in Treatment Naive Non-Cirrhotic G1 CHC China III

Who this might be right for
Chronic Hepatitis C
Ascletis Pharmaceuticals Co., Ltd. 141
Testing effectiveness (Phase 2)UnknownNCT01727934
What this trial is testing

Miravirsen Study in Null Responder to Pegylated Interferon Alpha Plus Ribavirin Subjects With Chronic Hepatitis C

Who this might be right for
Hepatitis C
Santaris Pharma A/S 10
Post-approval studies (Phase 4)Study completedNCT00077649
What this trial is testing

PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With COPEGUS (Ribavirin) in Interferon-Naive Patients With Chronic Hepatitis C Infection (CHC).

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 188
Not applicableWithdrawnNCT03113604
What this trial is testing

Analysis of the Role of Hepatocyte SLAMF3 Receptor and Drug Resistance Proteins (MDR) in Resistance to Treatment With Sorafenib in CHC Patients

Who this might be right for
Hepatocyte ReceptorHepatocellular Carcinoma
Centre Hospitalier Universitaire, Amiens
Not applicableNot Yet RecruitingNCT07569250
What this trial is testing

Increasing CRC Screening in Community Health Centers Through Mobile Messaging Optimization

Who this might be right for
Colorectal Cancer
University of Colorado, Denver 7,220
Post-approval studies (Phase 4)UnknownNCT02638233
What this trial is testing

Therapy With Ledipasvir/Sofosbuvir in Patients With Genotype 1 HCV Infection Receiving Opiate Substitution Therapy

Who this might be right for
Chronic Hepatitis C
Wilhelminenspital Vienna 40
Large-scale testing (Phase 3)Study completedNCT00411385
What this trial is testing

Efficacy of Albumin Interferon Alfa-2b With Ribavirin Compared to Peg-IFN Alfa-2a With Ribavirin in IFN Naive Patients Geno2/3

Who this might be right for
Chronic Hepatitis C
Human Genome Sciences Inc. 933
Large-scale testing (Phase 3)Study completedNCT00304551
What this trial is testing

Peginterferon Alfa-2a in Combination With Ribavirin in Chronic Hepatitis C (CHC) Patients With Compensated Liver Cirrhosis (LC)

Who this might be right for
Liver CirrhosisChronic Hepatitis C
Chugai Pharmaceutical 180
Early research (Phase 1)Study completedNCT02014571
What this trial is testing

Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of Repeat Doses of GSK2878175 in Subjects With Chronic Hepatitis C.

Who this might be right for
Hepatitis C, Chronic
GlaxoSmithKline 37
Large-scale testing (Phase 3)Study completedNCT00402428
What this trial is testing

Efficacy of Albumin Interferon Alfa-2b With Ribavirin Compared With Peg-IFN Alfa-2a With Ribavirin in IFN Naive Patients

Who this might be right for
Chronic Hepatitis C
Human Genome Sciences Inc. 1,331
Post-approval studies (Phase 4)Study completedNCT00087607
What this trial is testing

Peak Study - A Study of Pegasys (Peginterferon Alfa-2a (40KD)) in Combination With Copegus (Ribavirin) in Interferon-Naive Patients With Chronic Hepatitis C (CHC).

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 385

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation